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Abstract
Background: The concept of risk thresholds has been studied in medical decision making for over 30 years.
During that time, physicians have been shown to be poor at estimating the probabilities required to use this
method. To better assess physician risk thresholds and to more closely model medical decision making, we set out
to design and test a method that derives thresholds from actual physician treatment recommendations. Such an
approach would avoid the need to ask physicians for estimates of patient risk when trying to determine individual
thresholds for treatment. Assessments of physician decision making are increasingly relevant as new data are
generated from clinical research. For example, recommendations made in the setting of ocular hypertension are of
interest as a large clinical trial has identified new risk factors that should be considered by physicians. Precisely
how physicians use this new information when making treatment recommendations has not yet been determined.
Results: We derived a new method for estimating treatment thresholds using ordinal logistic regression and tested
it by asking ophthalmologists to review cases of ocular hypertension before expressing how likely they would be
to recommend treatment. Fifty-eight physicians were recruited from the American Glaucoma Society. Demographic
information was collected from the participating physicians and the treatment threshold for each physician was
estimated. The method was validated by showing that while treatment thresholds varied over a wide range, the
most common values were consistent with the 10-15% 5-year risk of glaucoma suggested by expert opinion and
decision analysis.
Conclusions: This method has advantages over prior means of assessing treatment thresholds. It does not require
physicians to explicitly estimate patient risk and it allows for uncertainty in the recommendations. These
advantages will make it possible to use this method when assessing interventions intended to alter clinical
decision making.
Background
The use of thresholds has been considered as a means
of making medical decisions for over 3 decades [1-3].
To utilize this method, physicians must be able to esti-
mate the baseline risk of each individual patient. Know-
ing the risk of the patient, the physician must also be
able to determine thresholds for risk above which they
will order additional testing or initiate treatment.
Furthermore, the physician must be able to determine
how a patient’s risk will change based on the result of a
particular test. If the test has no chance of moving the
patient’s risk above the treatment threshold, for exam-
ple, then the test should probably not be ordered.
There is, however, a body of evidence that documents
physicians’ inaccuracy in predicting the risk of individual
patients [4-8] and specifically in patients with ocular
hypertension [9]. There is also evidence that clinicians
do not use the threshold method when making decisions
[10] and that intuitive threshold estimates do not match
observed thresholds for treatment [11]. Given these pro-
blems with the estimation of ap r i o r irisk levels, the
threshold method becomes suspect as a prescriptive
means of rational decision making. On the other hand,
the concept of risk thresholds is potentially very useful
for comparing physicians to one another or for * Correspondence: boland@jhu.edu
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may therefore be useful to consider these descriptive
uses of thresholds differently from the problematic pre-
scriptive methods mentioned above.
One approach to determining physician treatment
thresholds is to provide the clinicians with case scenar-
ios and then ask them for an estimate of the probability
of disease and for their recommendation to treat or
treat. By varying the risk of disease represented by the
case scenarios, it is possible to identify a clinician’sr i s k
thresholds for either ordering additional testing or initi-
ating treatment [12]. This method still requires clini-
cians to estimate probabilities and because of this
requirement, it becomes very difficult to compare the
threshold derived from one physician to that of another.
Furthermore, there is no guarantee that the risk esti-
mates are based on any rational synthesis of evidence.
Finally, throughout the history of eliciting risk estimates,
physicians have both been uncomfortable in providing
numerical values and have expressed the need to com-
municate the uncertainty in those estimates [13].
Another approach to threshold determination removes
the need for clinicians to explicitly estimate any risk
whatsoever. Plasencia et al. described a method in
w h i c ht h e yu s e db i n a r yl o g i s tic regression to estimate
treatment thresholds [14]. Their method depends on
another advance in risk estimation, the synthesis of
large population based studies to produce risk calcula-
tors that can be used to estimate disease risk for a parti-
cular patient. The Framingham study provides a good
example of how risk factors found in epidemiologic
studies can be combined to summarize the risk of an
individual [15-17]. Since the risk associated with each
patient can now often be estimated based on published
evidence, it is no longer necessary to ask the clinicians
for their estimate of that risk. Instead, they can be asked
for their treatment recommendation only. Building on
the work of Hartz et al., [18] Plasencia and others used
binary logistic regression to estimate treatment thresh-
olds [14]. This method has the advantage of using the
same risk for each case scenario rather than using the
many intuitive estimates provided by clinicians. In this
way, it is possible to compare decision thresholds across
physicians.
One disadvantage of the logistic regression method is
that it requires concrete binary decisions be made.
Because uncertainty is an important component of clini-
cal decision making, [19] we developed a method for
assessing treatment thresholds that allowed clinicians to
make explicit use of their uncertainty. Given a situation
in which we can estimate the risk of glaucoma for any
patient with ocular hypertension, we set out to deter-
mine whether ordinal (as opposed to binary) logistic
regression could be used to derive physician treatment
thresholds from treatment recommendations made on a
set of clinical scenarios. By allowing for more than two
levels of recommendation (yes or no), we are also allow-
ing for physicians to express uncertainty.
As opposed to providing quantitative estimates of
patient risk, clinicians routinely make recommendations
t h a ta r ep r e s u m a b l yd r i v e nb yt h a ts a m ep a t i e n tr i s k ,
but implicitly so. We developed the proposed method to
take advantage of this fact and to derive some estimate
of physician interpretation of risk, as reflected by their
explicit treatment recommendations. There is clearly
still variability in physician behavior but the approach
allows us to analyze usual physician behavior (treatment
recommendations) rather than unusual behavior (assign-
ing quantitative risk).
While the literature is clear about clinicians’ inability
to quantify risk, the literature has little to say about the
ability of clinicians to state accurately whether a given
patient is above or below that risk. In fact, there is rea-
son to believe, given their general successful functioning,
that they are good at this task. It is this task that we
have quantified. As a first attempt at assessing this skill,
we have created a de facto random effects model, where
each clinician has their own threshold (and ability to
compare with respect to that threshold) sampled, in
turn, from a population threshold; it is that latter
threshold that we estimate with our regression model.
Furthermore, because prior research is clear that physi-
cians are unable to reliably assign a numeric value to a
particular patient’sr i s ko fap a r t i c u l a rd i s e a s eo ro u t -
come, we employed a method to discover the implicit
risk levels at which physicians change their behaviour.
This method will then let us compare the impact of
interventions like risk calculators, clinical decision
support tools, and physician education.
To evaluate our method, we chose to use ocular hyper-
tension (elevated eye pressure) as the condition under
study. Ocular hypertension is a known risk factor for
developing glaucoma, a significant cause of blindness
worldwide [20]. Because of its association with glaucoma,
ocular hypertension was the subject of a large clinical
trial, the Ocular Hypertension Treatment Study (OHTS)
[21]. The OHTS randomized over 1600 patients with ele-
vated eye pressure to either pressure lowering treatment
or observation and then monitored both groups for
development of glaucoma. Prior to the OHTS, it was not
clear which patients with ocular hypertension would ben-
efit from treatment to prevent glaucoma. Analysis of the
study has since clarified the risk factors associated with
the conversion from ocular hypertension to glaucoma.
Among the most important outcomes of the OHTS have
been risk calculators that can be used to estimate the risk
of developing glaucoma in individual patients [22-24].
Such calculators may be able to help physicians identify
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are important as an objective measure of risk in the
method we describe. Although we chose to evaluate this
method using ocular hypertension as the disease in ques-
tion, this approach will be applicable to any disease pro-
cess for which experimenters can calculate the risk of an
outcome for each patient presented to the physicians
under study. Examples include cardiovascular risk or
cancer mortality.
Results
In brief, the method we propose to analyze treatment
recommendations allows physicians to express their
recommendations using an ordinal scale that includes
uncertainty. The seven-point scale used here ranged
from ‘Definitely No’ (no treatment) to ‘Definitely Yes’.
These responses are then analyzed using ordinal regres-
sion to estimate the point of maximal uncertainty for
each physician.
This work was approved by the institutional review
board of the Johns Hopkins University School of Medi-
cine and adhered to the tenets of the Declaration of
Helsinki.
Algorithm
The role of ordinal regression in this method is
depicted graphically in Figure 1. Four arbitrary levels
of disease risk are shown. For each level of risk, it is
assumed that there is a continuous variable represent-
ing the likelihood of physicians recommending treat-
ment. The vertically oriented normal distributions
depict the distribution of this underlying variable at
each level of risk. As disease risk increases, this distri-
bution shifts upward, indicating that physicians are
more likely to recommend treatment. Since this con-
tinuous variable cannot be measured directly, however,
it is modelled in practice by an ordinal ranking (Yes,
Unsure, No). For the purposes of this method, this
ordinal variable represents physician likelihood to
recommend treatment. The two intercepts in the ordi-
nal regression model (aU, aY) represent the break
points between the three levels of the ordinal scale.
The point we have defined as the treatment threshold
is the level of risk at which the likelihood of a Yes
recommendation and a No recommendation are equal.
This point is represented at the “Intermediate” risk
level in the figure.
From the definition of ordinal regression, [25,26] the
following relationship exists between the treatment
recommendation (t)a n dt h ep a t i e n t ’s risk of disease (r),
where j is the level of recommendation on the ordinal
scale (No, Unsure, Yes), aj is the intercept coefficient
for that level, b is the regression coefficient for risk, and
P() indicates probability.
Pt j
e j r () () 
 
1
1  (1)
To estimate each physician’s threshold for recom-
mending treatment, we are interested in the value for
r i s ka tw h i c ht h e ya r ee q u a l l yl i k e l yt om a k eaY e so r
No recommendation (i.e., are maximally unsure).
Pt N o Pt Y e s () ()   (2)
Using the fact that the possible recommendations, No,
Unsure, and Yes are ordinal, we know that the probabil-
ity of a No recommendation is the probability of a
recommendation greater than or equal to No minus the
probability of a recommendation greater than or equal
to Unsure. Since there are no recommendations less
than No, the probability of a recommendation greater
than or equal to No is 1.
Pt N o Pt N o Pt U n s u r e Pt U n s u r e ( ) ( ) () ()       1 (3)
Furthermore, we know that the probability of a Yes
recommendation is equal to the probability of a recom-
mendation greater than or equal to Yes since there are
no recommendations beyond Yes.
Pt Y e s Pt Y e s () ()   (4)
Combining Equations 1,3, and 4, we can generate
expressions for the probability of Yes and No recom-
mendations in terms of risk and the ordinal regression
coefficients.
Pt N o
e Unsure r
Pt Y e s
e Yes r
()
()
()
()
 
 

 
1
1
1
1
1


Setting these two equations equal to each other and
solving for risk produces the following:
r
yes Unsure 
 
 2
For each participating physician we performed ordinal
regression on their treatment recommendations and then
calculated r as an estimate of their treatment threshold. For
physicians who only used No and Yes in their recommen-
dations (2 physicians), we used logistic regression in the
same way described by Plasencia. The instances where phy-
sicians use only two categories of response are really special
cases of the full three level problem in that those physicians
are never unsure of their decisions. By defining the thresh-
old for recommending treatment to be the point at which
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we are really using the same model for both groups while
still allowing the majority of physicians to express uncer-
tainty. Finally, for those clinicians who never recommended
treatment (3 physicians), we assigned a threshold equal to
the average of the highest calculated risk among the simu-
lated cases and 100%. This estimates the risk threshold for
this subgroup of physicians as falling between the highest
risk in our cases (which was too low for them to recom-
mend treatment) and the highest possible risk (100%).
Although this choice is somewhat arbitrary, we believe this
approach is appropriate given that we know these physi-
cians would probably not treat patients with even the high-
est risk in our case scenarios and also know that they
sometimes recommend treatment of ocular hypertension
(they denied that they “never” treated these patients as part
of the study). Threshold values were calculated for each
physician rather than for the entire group in order to cap-
ture the expected differences in their likelihood to treat
ocular hypertension. This within-subject analysis is sup-
ported by prior work using expectancy-value models [27].
Testing
To simulate the patient population of the OHTS, 50
cases of ocular hypertension were generated using the
summary statistics of the OHTS population [28]. Each
simulated case was a list of patient attributes instan-
tiated with specific values. The attributes known from
the OHTS study to be risk factors for initial glaucoma
are age, intraocular pressure (IOP), cup-disc ratio
(CDR), pattern standard deviation (PSD) from auto-
mated field testing, central corneal thickness (CCT),
and self-reported diabetes mellitus. We chose to use
only the known risk factors for the development of
glaucoma so that, given a sample size of 50 physicians,
we could avoid under-determined multivariate models.
We created scenarios by generating values from the
published proportions, means and standard deviations
from the OHTS population. Values for the continuous
parameters were drawn from normal distributions.
Where appropriate, values of risk factors in our sce-
narios were restricted based on OHTS inclusion and
exclusion criteria [29]. The estimated 5-year risk of
glaucoma was then calculated for each scenario using
the equation described by Medeiros et al. [23] The
model underlying this calculator produced a concor-
dance index between 0.68 and 0.73, though they did
not report any other statistics indicating how much of
the true variability in risk their model was able to
explain.
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Figure 1 A graphical representation of the role of ordinal regression in this method. The four risk levels are arbitrary and chosen for
illustrative purposes only. The normal distribution shown at each risk level represents the assumed underlying continuous probability of
treatment recommendation that is being assessed using the ordinal scale (Yes, Unsure, No). The two thresholds (aU, aY) are the intercepts
derived from ordinal regression analysis of physician responses and form the boundaries between the three response levels.
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members of the American Glaucoma Society (AGS)
over the course of two weeks. Although the AGS was
not able to confirm the number of active participants on
the society e-mail list, the total membership was
approximately 500 at the time of the survey. To prevent
bias in recruitment of physicians, recipients were not
told the specific nature of the study, only that they
would be reviewing cases of ocular hypertension.
Because of the estimated time required to complete the
study (30-45 minutes) and to further reduce any selec-
tion bias, they were also offered compensation of $150
for their time. Enrolment in the study was stopped
when we surpassed the target of 50 subjects.
Once they accessed the study web site, physicians
were provided with a brief consent document. If they
agreed to participate, they were first asked questions
intended to identify and exclude physicians who either
always or never treat ocular hypertension. Physicians
who did not report using intraocular pressure as the
sole criteria for treatment were then asked to review 50
case scenarios without being given the estimated risk of
conversion to glaucoma. Participants were instructed to
review the scenarios that included values for all six
OHTS-derived risk factors plus patient gender. For each
simulated patient, the physicians were asked how likely
they would be to recommend treatment to prevent glau-
coma. Participants were explicitly instructed that this
recommendation represented their initial position in
their discussion with the patient. Responses were
recorded along a seven-point scale that included ‘Defi-
nitely No’ (no treatment), ‘Probably No’, ‘Possibly No’,
‘Unsure’, ‘Possibly Yes’, ‘Probably Yes’,a n d‘Definitely
Yes’ with the goal of collapsing them into three groups
for the purpose of analysis.
After completing the study, participants were all asked
to provide their gender, racial background, number of
years in practice, subspecialty training, monthly clinic
volume, fraction of practice devoted to glaucoma, and
use of a risk calculator in their practice.
As the first step in analyzing the physician responses,
the seven-point treatment recommendation scale was
collapsed into three levels. ‘Definitely No’ and ‘Probably
No’ were combined as ‘No’. ‘Possibly No’, ‘Unsure’,a n d
‘Possibly Yes’ were combined as ‘Unsure’, while ‘Prob-
ably Yes’ and ‘Definitely Yes’ were labelled ‘Yes’.T h e
choice of a 3-point scale was made to facilitate interpre-
tation of the subsequent regression analysis and to
ensure an adequate number of responses in each cate-
gory. The particular mapping was chosen to move
responses from the 7-point scale to the nearest value in
the 3-point scale while still explicitly maintaining the
concept of “unsure”. There is evidence that 3-point
scales are adequate [30] and this approach is suggested
for Likert-scale data in order to make subsequent analy-
sis more understandable [31,32]. The treatment recom-
mendations were then analyzed using ordinal regression
as described above to identify the treatment threshold
for each physician.
Implementation
The distribution of glaucoma risk in our simulated
population is shown in Figure 2. Risk is distributed in a
truncated log-normal fashion and this simulated popula-
tion is similar to a population of patients reported by
Medeiros et al. as part of the Diagnostic Innovations in
Glaucoma Study (DIGS) [23]. The DIGS population had
an average predicted risk of 14.3% while our simulated
cases had an average predicted risk of 13.8%. Further-
more, the actual glaucoma risk of those DIGS subjects
with a predicted risk above 15% was 26%, which is iden-
tical to the risk of the same group in our simulated
population. The simulated cases therefore represent a
good approximation to “real” patients as they were cre-
ated using statistics for risk factors derived from the
results of a clinical trial (OHTS) and because the overall
distribution of glaucoma risk is the same as that in a
cohort study (DIGS).
The physicians participating in the study were all
members of the AGS and their demographic attributes
are summarized in Table 1. The fact that these subjects
were drawn from a subspecialty group is reflected both
in the high percentage of subspecialty training and in
the percentage of their practice devoted to glaucoma.
This group is therefore not representative of most
ophthalmologists. Because membership demographics
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Figure 2 The distribution of the 5-year risk of glaucoma.T h e
distribution of the 5-year risk of glaucoma in the population from
which the 50 simulated cases were drawn. The solid line is a log-
normal distribution with the same mean and variance of risk as the
simulated cases.
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determine the degree to which these participants were
representative of the organization as a whole. Of the 58
participants in the study, two of them indicated that
they treat all patients with eye pressure above 21
mmHg. Because these two physicians were not using
the overall risk of glaucoma as the basis for their treat-
ment recommendations, they were excluded from
further analysis.
Using the threshold estimation method described
above, a treatment threshold was calculated for each of
the 56 remaining physicians using ordinal regression as
described in Methods (Figure 3). The average treatment
threshold over all 56 physicians was a 23% chance of
conversion to glaucoma over five years. Because the dis-
tribution of derived treatment thresholds was skewed to
the right, however, the most common values fell
between 10 and 20% which are similar to suggested
treatment thresholds derived from expert opinion (15%
5 year risk) [33] and from decision analysis (10% 5 year
risk) [34]. The distribution of thresholds also captures
the fact that some physicians would treat all or almost
all of the cases to prevent glaucoma (far left in Figure 3)
and that some would treat none or almost none of them
(far right in Figure 3).
Statistics were calculated for the ordinal regression
model calculated for each physician. The average R
2
value (using the method of Nagelkerke) was 0.40 with a
standard deviation of 0.14. The concordance index,
w h i c hi st h es a m ea st h ea r e au n d e rt h ec u r v ei nR O C
analysis, had an average value of 0.81 with a standard
deviation of 0.06. This value for concordance is actually
better than that for the risk calculator model mentioned
above (0.68 to 0.71).
Discussion
We have defined and applied a new method for asses-
sing treatment thresholds that accommodates uncer-
tainty in physician treatment recommendations. In
settings for which patient risk can be objectively esti-
mated, this method provides estimates of the risk
threshold for individual physicians using only their
treatment recommendations. Like Plasencia et al.,o u r
method avoids the problem of asking physicians for
explicit estimates of patient risk. This feature is impor-
tant, as there is now a body of work supporting the con-
tention that physicians are, as a group, not effective at
making such estimates. In contrast to Plasencia et al.,
our method is not restricted to binary (yes/no) treat-
ment recommendations. By allowing for uncertainty on
the part of physicians, the method described above is
more reflective of medical decision making [19].
Using simulated cases of ocular hypertension to evalu-
ate our method, we found that the participating physi-
cians were most likely to recommend treatment at a risk
level supported by expert opinion or by formal decision
analysis. There was, however, a wide range of risk
thresholds with some physicians recommending treat-
ment in most cases and some recommending treatment
in almost none. Such inter-physician variability is
Table 1 Demographics of study participants
Number [%]
Gender (Male) 48 [83]
Racial Background
Asian 9 [16]
Black 2 [3.4]
White 41 [71]
Other or None 6 [10]
Glaucoma Training 57 [98]
Risk Calculator Use
Never 31 [53]
Sometimes 25 [43]
Always 2 [3.4]
Mean (std. dev.)
Length of practice (years) 16.8 (10.2)
Patients seen per month 444 (217)
Percentage of Practice Devoted to Glaucoma 77 (20)
All values are derived from self-reported data provided by study participants
(N = 58). Glaucoma Training refers to the number of participants who had
subspecialty training and Risk Calculator Use indicates how frequently the
participants used one of the available risk calculators in their practice.
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Figure 3 The distribution of estimated treatment thresholds
for glaucoma specialists. The solid line shows a beta distribution
with coefficients a = 2.56 and b = 9.14. The coefficients of the beta
distribution were obtained using a maximum-likelihood method
(fitdistr in R) and have standard errors of 0.48 and 1.83
respectively.
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derived treatment thresholds using physician risk esti-
mates [12].
We also found that the combination of physician
responses and our model showed good prediction of the
estimated risk, at least as measured by the concordance
index. The R
2 values calculated for each physician’s
ordinal regression model did suggest that there is a sig-
nificant proportion of risk that is not explained by phy-
sician recommendations, however. This problem is not
inherent in our model and is more likely due to variabil-
ity in physician ability to estimate risk, either explicitly
or through their clinical decisions.
One trade-off made in the design of our study was the
use of simulated cases rather than “real” patients. While
it is possible to argue that this reduces the ability to
generalize our results, we made every effort to ensure
our cases were as representative as possible. Specifically,
we used the demographic and risk factor statistics from
the OHTS to generate our cases and we compared the
risk profile from our population to that of a cohort
study independent of the OHTS. For these reasons, and
because we had to present only numeric data to the
participating physicians, we believe our cases were
representative of cases of ocular hypertension available
in clinic.
Alternative approaches to analyzing response data
include both item response theory and Rasch analysis.
Both of these methods are intended for analysis of
events (case scenarios or test questions) across indivi-
duals. Because the quantity we are interested in here is
some measure of risk tolerance by physicians, we
needed a method that described responses within a
respondent across those events (case scenarios). For this
reason, we did not feel item response or Rasch theory
was most appropriate.
This approach to estimating physician treatment
thresholds has a potential role in the evaluation of inter-
ventions designed to modify physician behaviour. For
example, one might be interested in assessing the
impact of a decision support tool on the treatment
recommendations made by physicians. Such tools
include the risk calculators that are now available for
ocular hypertension and other conditions, providing the
clinician with an explicit estimate of patient risk. By cal-
culating risk thresholds for recommendations made
both with and without the support tool, it will be possi-
ble to determine how the tool impacts physician deci-
sions in terms of how much risk of disease they are
willing to tolerate before recommending treatment. As a
numeric value, these risk thresholds are also amenable
to a variety of analyses that might not be possible with
more subjective measures. Elicitation of decision thresh-
olds in this way may also lead to better customization of
decision support systems, which may, in turn, improve
adoption [35].
In future studies, the threshold we calculate will be
used as an outcome measure. For instance, to assess the
impact of a decision support tool on clinicians, we will
be able to assess the (implicit) threshold before and dur-
ing/after use of such a calculator. Similarly, we will
assess the impact of patient characteristics on the impli-
cit threshold, and to see if characteristics beyond those
that are evidence-based have an effect on clinical deci-
sions. Such discoveries may help explain treatment
variability among ophthalmologists or other clinicians.
Conclusions
In summary, we have described a new method for asses-
sing physician risk thresholds using only empiric, uncer-
tain treatment recommendations. This method has
advantages over prior work in that it does not require
physicians to estimate risk directly and allows them to
be uncertain in their recommendations. We have tested
this method using simulated cases of ocular hyperten-
sion and found wide variability in physician risk thresh-
olds with the most common values near thresholds
suggested by expert opinion and decision analysis. Based
on the characteristics of the method, we believe it has
potential as a means of assessing the impact on physi-
cian recommendations of decision support tools.
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